On the public citation graph
https://doi.org/10.2139/ssrn.4576076
0 signed · 26 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1521-4141(200103)31:3<692::aid-immu692>3.0.co;2-yopenalex-extracted
Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection
inferredcites →https://doi.org/10.1002/eji.1830211217openalex-extracted
Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein
inferredcites →https://doi.org/10.1016/j.coi.2018.04.023openalex-extracted
From human antibody structure and function towards the design of a novel Plasmodium falciparum circumsporozoite protein malaria vaccine
inferredcites →https://doi.org/10.1016/j.immuni.2020.08.014openalex-extracted
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
inferredcites →https://doi.org/10.1016/j.mib.2016.04.006openalex-extracted
Malaria vaccines and human immune responses
inferredcites →https://doi.org/10.1016/j.vaccine.2008.09.097openalex-extracted
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity
inferredcites →https://doi.org/10.1016/j.vaccine.2020.12.055openalex-extracted
Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine
inferredcites →https://doi.org/10.1016/s0020-7519(01)00184-9openalex-extracted
DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation
inferredcites →https://doi.org/10.1016/s0140-6736(15)60721-8openalex-extracted
Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial
inferredcites →https://doi.org/10.1016/s0264-410x(99)00407-7openalex-extracted
Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
inferredcites →https://doi.org/10.1016/s1473-3099(15)00239-xopenalex-extracted
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
inferredcites →https://doi.org/10.1038/nm.4512openalex-extracted
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
inferredcites →https://doi.org/10.1038/nm.4513openalex-extracted
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
inferredcites →https://doi.org/10.1038/s41467-019-10195-zopenalex-extracted
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
inferredcites →https://doi.org/10.1084/jem.20170869openalex-extracted
Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
inferredcites →https://doi.org/10.1084/jem.20200061openalex-extracted
A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity
inferredcites →https://doi.org/10.1084/jem.20201313openalex-extracted
How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein
inferredcites →https://doi.org/10.1093/infdis/jiv154openalex-extracted
Proteolytic Cleavage of thePlasmodium falciparumCircumsporozoite Protein Is a Target of Protective Antibodies
inferredcites →https://doi.org/10.1126/science.6204383openalex-extracted
Structure of the Gene Encoding the Immunodominant Surface Antigen on the Sporozoite of the Human Malaria Parasite Plasmodium falciparum
inferredcites →https://doi.org/10.1128/iai.00728-20openalex-extracted
Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from Plasmodium Infection in a Murine Model
inferredcites →https://doi.org/10.1128/iai.02676-14openalex-extracted
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains
inferredcites →https://doi.org/10.1146/annurev.iy.11.040193.003351openalex-extracted
T Cell Responses to Pre-Erythrocytic Stages of Malaria: Role in Protection and Vaccine Development Against Pre-Erythrocytic Stages
inferredcites →https://doi.org/10.1186/s12936-019-3055-9openalex-extracted
Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages
inferredcites →https://doi.org/10.1371/journal.ppat.1010409openalex-extracted
A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum
inferredcites →https://doi.org/10.3390/vaccines10071134openalex-extracted
Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission
inferredcites →https://doi.org/10.4161/hv.6.1.9677openalex-extracted
From the circumsporozoite protein to the RTS,S/AS candidate vaccine
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.